Hester Biosciences Limited share price
NSE: HESTERBIO · ISIN INE782E01017
Key numbers
- Market cap
- -
- Current price
- ₹ 2,182.90
- 52-week high / low
- ₹ 2,684 / 1,239
- Stock P/E
- 13.8
- Book value
- ₹ 423.5
- Dividend yield
- 0.50%
- ROCE
- 15.4%
- ROE
- 16.5%
- Debt to equity
- 0.54
- Sales growth (3 yrs)
- 7.7%
- Profit growth (3 yrs)
- 27.8%
- 1-year return
- 9.4%
About Hester Biosciences Limited
Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutics, nutritional supplements, and specialised formulations to enhance animal wellness and productivity. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming products, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, farm hygiene, vitamins, minerals, and specialty feed supplements for critical…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 84 | 71 | 77 | 100 | 77 |
| Operating profit | 23 | 12 | 18 | 34 | 23 |
| Net profit | 16 | 14 | 9 | 16 | 97 |
| EPS (₹) | 20.33 | 16.85 | 10.94 | 19.45 | 113.71 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.